Erratum: Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss (Journal Immunology (2013) 190 (1148-1157) DOI: 10.4049/jimmunol.1202511);Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-Dependent inflammatory oral bone loss

Journal of Immunology

Volumn 190, Issue 3, 2013, Pages 1148-1157

  Papadopoulos, George ^a   Weinberg, Ellen O ^a   Massari, Paola ^a   Gibson, Frank C ^a   Wetzler, Lee M ^a   Morgan, Elise F ^b   Genco, Caroline A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ADOPTIVE TRANSFER; ALVEOLAR BONE LOSS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM MUTANT; BONE MARROW; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEEDBACK SYSTEM; FIMBRIA; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VIVO STUDY; INFLAMMATION; KNOCKOUT MOUSE; MACROPHAGE; MALE; MOUSE; MOUTH INFECTION; NONHUMAN; PATHOPHYSIOLOGY; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 84872725017     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.2200589     Document Type: Erratum

References (62)

1. Pihlstrom, B. L., B. S. Michalowicz, and N. W. Johnson. 2005. Periodontal diseases. Lancet 366: 1809-1820. (Pubitemid 41642647)
2. Eke, P. I., G. O. Thornton-Evans, L. Wei, W. S. Borgnakke, and B. A. Dye. 2010. Accuracy of NHANES periodontal examination protocols. J. Dent. Res. 89: 1208-1213.
3. Yang, H.-W., Y.-F. Huang, and M.-Y. Chou. 2004. Occurrence of Porphyromonas gingivalis and Tannerella forsythensis in periodontally diseased and healthy subjects. J. Periodontol. 75: 1077-1083. (Pubitemid 39276490)
4. Hajishengallis, G., S. Liang, M. A. Payne, A. Hashim, R. Jotwani, M. A. Eskan, M. L. McIntosh, A. Alsam, K. L. Kirkwood, J. D. Lambris, et al. 2011. Lowabundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10: 497-506.
5. Gibson, F. C., III, and C. A. Genco. 2007. Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: Disparate diseases with commonalities in pathogenesis through TLRs. Curr. Pharm. Des. 13: 3665-3675.
6. Hayashi, C., C. V. Gudino, F. C. Gibson, III, and C. A. Genco. 2010. Review: Pathogen-induced inflammation at sites distant from oral infection: Bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol. Oral Microbiol. 25: 305-316.
7. Liao, F., Z. Li, Y. Wang, B. Shi, Z. Gong, and X. Cheng. 2009. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitisassociated rheumatoid arthritis. Med. Hypotheses 72: 732-735.
8. Kiran, M., N. Arpak, E. Unsal, and M. F. Erdogan. 2005. The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. J. Clin. Periodontol. 32: 266-272. (Pubitemid 40462659)
9. Gibson, F. C., III, T. Ukai, and C. A. Genco. 2008. Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis. Front. Biosci. 13: 2041-2059. (Pubitemid 351589233)
10. Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826. (Pubitemid 47598622)
11. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1: 135-145. (Pubitemid 33741967)
12. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511. (Pubitemid 38931765)
13. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801. (Pubitemid 43261452)
14. Beutler, B. 2009. Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol. Rev. 227: 248-263.
15. Nathan, C., and A. Ding. 2010. Nonresolving inflammation. Cell 140: 871-882.
16. Biswas, S. K., and E. Lopez-Collazo. 2009. Endotoxin tolerance: New mechanisms, molecules and clinical significance. Trends Immunol. 30: 475-487.
17. Park, S. H., K.-H. Park-Min, J. Chen, X. Hu, and L. B. Ivashkiv. 2011. Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages. Nat. Immunol. 12: 607-615.
18. Foster, S. L., D. C. Hargreaves, and R. Medzhitov. 2007. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978. (Pubitemid 46975746)
19. Dubois, B., A. Goubier, G. Joubert, and D. Kaiserlian. 2005. Oral tolerance and regulation of mucosal immunity. Cell. Mol. Life Sci. 62: 1322-1332. (Pubitemid 40853819)
20. Abraham, C., and R. Medzhitov. 2011. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 140: 1729-1737.
21. Hedl, M., J. Li, J. H. Cho, and C. Abraham. 2007. Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc. Natl. Acad. Sci. USA 104: 19440-19445.
22. Muthukuru, M., R. Jotwani, and C. W. Cutler. 2005. Oral mucosal endotoxin tolerance induction in chronic periodontitis. Infect. Immun. 73: 687-694. (Pubitemid 40165723)
23. Malek, R., J. G. Fisher, A. Caleca, M. Stinson, C. J. van Oss, J. Y. Lee, M. I. Cho, R. J. Genco, R. T. Evans, and D. W. Dyer. 1994. Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J. Bacteriol. 176: 1052-1059. (Pubitemid 24060122)
24. Gibson, F. C., III, C. Hong, H.-H. Chou, H. Yumoto, J. Chen, E. Lien, J.Wong, and C. A. Genco. 2004. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 109: 2801-2806. (Pubitemid 38737928)
25. Wang, M., M.-A. K. Shakhatreh, D. James, S. Liang, S.-I. Nishiyama, F. Yoshimura, D. R. Demuth, and G. Hajishengallis. 2007. Fimbrial proteins of Porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages. J. Immunol. 179: 2349-2358.
26. Davey, M., X. Liu, T. Ukai, V. Jain, C. Gudino, F. C. Gibson, III, D. Golenbock, A. Visintin, and C. A. Genco. 2008. Bacterial fimbriae stimulate proinflammatory activation in the endothelium through distinct TLRs. J. Immunol. 180: 2187-2195.
27. Zhou, Q., T. Desta, M. Fenton, D. T. Graves, and S. Amar. 2005. Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect. Immun. 73: 935-943. (Pubitemid 40165752)
28. Zhou, Q., and S. Amar. 2007. Identification of signaling pathways in macrophage exposed to Porphyromonas gingivalis or to its purified cell wall components. J. Immunol. 179: 7777-7790.
29. Burns, E., G. Bachrach, L. Shapira, and G. Nussbaum. 2006. Cutting edge: TLR2 is required for the innate response to Porphyromonas gingivalis: Activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J. Immunol. 177: 8296-8300. (Pubitemid 44893789)
30. Liang, S., J. L. Krauss, H. Domon, M. L. McIntosh, K. B. Hosur, H. Qu, F. Li, A. Tzekou, J. D. Lambris, and G. Hajishengallis. 2011. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J. Immunol. 186: 869-877.
31. Ukai, T., H. Yumoto, F. C. Gibson, III, and C. A. Genco. 2008. Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires Toll-like receptor 2-dependent tumor necrosis factor-alpha production. Infect. Immun. 76: 812-819. (Pubitemid 351251754)
32. Bradley, J. R. 2008. TNF-mediated inflammatory disease. J. Pathol. 214: 149-160. (Pubitemid 351160153)
33. Kollias, G. 2005. TNF pathophysiology in murine models of chronic inflammation and autoimmunity. Semin. Arthritis Rheum. 34(Suppl. 1): 3-6.
34. Falvo, J. V., A. V. Tsytsykova, and A. E. Goldfeld. 2010. Transcriptional control of the TNF gene. Curr. Dir. Autoimmun. 11: 27-60.
35. Roux, C. 2011. Anti-TNFa therapy and prevention of bone loss in rheumatoid arthritis. IBMS BoneKEy 8: 154-158.
36. Boyce, B. F., P. Li, Z. Yao, Q. Zhang, I. R. Badell, E. M. Schwarz, R. J. O'Keefe, and L. Xing. 2005. TNF-alpha and pathologic bone resorption. Keio J. Med. 54: 127-131.
37. Assuma, R., T. Oates, D. Cochran, S. Amar, and D. T. Graves. 1998. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J. Immunol. 160: 403-409. (Pubitemid 28116755)
38. Abu-Amer, Y., F. P. Ross, J. Edwards, and S. L. Teitelbaum. 1997. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J. Clin. Invest. 100: 1557-1565. (Pubitemid 27425783)
39. Takahashi, Y., M. Davey, H. Yumoto, F. C. Gibson, III, and C. A. Genco. 2006. Fimbria-dependent activation of pro-inflammatory molecules in Porphyromonas gingivalis infected human aortic endothelial cells. Cell. Microbiol. 8: 738-757.
40. Baker, P. J., R. T. Evans, and D. C. Roopenian. 1994. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch. Oral Biol. 39: 1035-1040. (Pubitemid 124034593)
41. Kong, Y. Y., H. Yoshida, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323.
42. Algood, H. M. S., P. L. Lin, D. Yankura, A. Jones, J. Chan, and J. L. Flynn. 2004. TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infection. J. Immunol. 172: 6846-6857. (Pubitemid 38669123)
43. Roach, D. R., A. G. D. Bean, C. Demangel, M. P. France, H. Briscoe, and W. J. Britton. 2002. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 168: 4620-4627. (Pubitemid 34441368)
44. Latz, E. 2010. The inflammasomes: Mechanisms of activation and function. Curr. Opin. Immunol. 22: 28-33.
45. Liew, F. Y., D. Xu, E. K. Brint, and L. A. J. O'Neill. 2005. Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5: 446-458. (Pubitemid 40835033)
46. Hajishengallis, G., M. Wang, and S. Liang. 2009. Induction of distinct TLR2-mediated proinflammatory and proadhesive signaling pathways in response to Porphyromonas gingivalis fimbriae. J. Immunol. 182: 6690-6696.
47. Hajishengallis, G., M. Wang, E. Harokopakis, M. Triantafilou, and K. Triantafilou. 2006. Porphyromonas gingivalis fimbriae proactively modulate beta2 integrin adhesive activity and promote binding to and internalization by macrophages. Infect. Immun. 74: 5658-5666. (Pubitemid 44484549)
48. Harokopakis, E., and G. Hajishengallis. 2005. Integrin activation by bacterial fimbriae through a pathway involving CD14, Toll-like receptor 2, and phosphatidylinositol-3-kinase. Eur. J. Immunol. 35: 1201-1210. (Pubitemid 40542227)
49. Park, Y. M., M. Febbraio, and R. L. Silverstein. 2009. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J. Clin. Invest. 119: 136-145.
50. Lam, J., S. Takeshita, J. E. Barker, O. Kanagawa, F. P. Ross and S. L. Teitelbaum. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106: 1481-1488. (Pubitemid 32038586)
51. Fuller, K., C. Murphy, B. Kirstein, S. W. Fox, and T. J. Chambers. 2002. TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 143: 1108-1118. (Pubitemid 34164059)
52. Kitaura, H., M. S. Sands, K. Aya, P. Zhou, T. Hirayama, B. Uthgenannt, S. Wei, S. Takeshita, D. V. Novack, M. J. Silva, et al. 2004. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J. Immunol. 173: 4838-4846. (Pubitemid 39387764)
53. Wei, S., H. Kitaura, P. Zhou, F. P. Ross, and S. L. Teitelbaum. 2005. IL-1 mediates TNF-induced osteoclastogenesis. J. Clin. Invest. 115: 282-290. (Pubitemid 40385470)
54. Phulwani, N. K., N. Esen, M. M. Syed, and T. Kielian. 2008. TLR2 expression in astrocytes is induced by TNF-alpha-and NF-kappa B-dependent pathways. J. Immunol. 181: 3841-3849.
55. Syed, M. M., N. K. Phulwani, and T. Kielian. 2007. Tumor necrosis factor-alpha (TNF-alpha) regulates Toll-like receptor 2 (TLR2) expression in microglia. J. Neurochem. 103: 1461-1471. (Pubitemid 47631804)
56. Haehnel, V., L. Schwarzfischer, M. J. Fenton, and M. Rehli. 2002. Transcriptional regulation of the human Toll-like receptor 2 gene in monocytes and macrophages. J. Immunol. 168: 5629-5637. (Pubitemid 34556144)
57. Wang, T., W. P. Lafuse, and B. S. Zwilling. 2000. Regulation of Toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J. Immunol. 165: 6308-6313.
58. Musikacharoen, T., T. Matsuguchi, T. Kikuchi, and Y. Yoshikai. 2001. NF-kappa B and STAT5 play important roles in the regulation of mouse Toll-like receptor 2 gene expression. J. Immunol. 166: 4516-4524. (Pubitemid 32233736)
59. Rahman, M. M., and G. McFadden. 2011. Modulation of NF-kB signalling by microbial pathogens. Nat. Rev. Microbiol. 9: 291-306.
60. Rosen, H., and S. Gordon. 1990. The role of the type 3 complement receptor in the induced recruitment of myelomonocytic cells to inflammatory sites in the mouse. Am. J. Respir. Cell Mol. Biol. 3: 3-10.
61. Harris, J., J. C. Hope, and J. Keane. 2008. Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis. J. Infect. Dis. 198: 1842-1850.
62. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, et al. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94: 8093-8098. (Pubitemid 27343782)